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The Association of Head Circumference With Selected Cognitive  
Outcomes in Older Adults in Charlotte County, Florida 
 
Cathleen Copenhaver 
ABSTRACT 
OBJECTIVE: The brain reserve hypothesis was examined in a secondary analysis 
of cross-sectional data from a community-based sample of 468 older adults residing in 
Charlotte County, Florida.  The objective of the analysis was to determine the association 
between head circumference and eight cognitive outcomes and to assess any potential 
effect modification of existing associations by Apolipoprotein E (APOE) genotype. 
METHODS: Cognitive outcomes include scores from the Modified Mini-Mental State 
Exam (3MS), the Hopkins Verbal Learning Test-Revised (HVLT-R), Stroop Color-Word 
Test, Trail-Making Test A and B, and a word-stem completion task measuring implicit 
memory. Descriptive statistics were calculated for each variable.  Head circumference 
and dependent cognitive outcomes were modeled as dichotomous variables using logistic 
regression, adjusting for gender, age, education, income, height, and Spot The Word test 
score, a measure of pre-morbid IQ.  For dichotomized test scores, poor outcomes (cases) 
were defined as having scores in the lowest quintile; the remaining top four quintiles 
were considered non-cases.  RESULTS: Small head circumference was significantly 
associated with low 3MS scores [OR(95%CI): 2.97 (1.12, 7.89), p=0.03], after 
adjustment for age, income and pre-morbid IQ.  The association remained statistically 
 v
significant after adjustment for gender and education as well.  After adjustment, head 
circumference was not found to be statistically significantly associated with any other 
cognitive outcome.  No effect modification was found by APOE genotype or years of 
education.  CONCLUSION: This analysis confirms previous findings that exposure to 
low head circumference significantly impacts cognition in late life. 
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Chapter 1 
Introduction 
 This thesis offers an analysis of data from a community-based survey of older 
adults in Charlotte County, Florida.  The purpose of the Charlotte County Healthy Aging 
Study (CCHAS) is to identify risk factors for cognitive function, and to understand life 
satisfaction and quality of life among an elder population.  The objective of the current 
analysis is to study head circumference as a risk factor for cognitive function under the 
brain reserve hypothesis, and to examine any existing association for modification by 
genetic predisposition to Alzheimer’s disease. 
 Head circumference has been studied previously as a risk factor for dementia and 
for neuropsychological outcomes. However, many of the cognitive outcomes examined in 
this analysis have not yet been adequately addressed within the literature on head size and 
cognition under the brain reserve hypothesis.  This thesis seeks to address that gap by 
analyzing the risk due to smaller head circumference of poor outcomes among eight well-
known neuropsychological tests.  These tests are often used within a standard battery for 
identifying dementia and cognitive impairment among the elderly.  While it is unlikely 
that head circumference will become part of a standard clinical risk profile for dementia, 
the etiological knowledge gained from discovery of its influence on these tests will be 
invaluable.  Through this knowledge, a better understanding of the determinants of 
clinical presentation of dementia can be achieved, leading to potential new prevention 
2 
therapies that capitalize on modifiable components of individual reserve capacity against 
cognitive decline. 
 In the following pages, a detailed explanation of the brain reserve hypothesis will 
be presented, along with thorough coverage of the existing literature on the subject of 
head size and cognition.  This background will be found in chapter two, followed by a 
description of the population of CCHAS and the methods used in that study and in this 
analysis in chapter three.  Description of the eight cognitive tests under study will also be 
provided in chapter three.  In chapter four, the results of this analysis will be presented, 
and a detailed discussion of the results and their interpretation will follow in chapter five.   
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Chapter 2 
Background 
Dementia and cognitive impairment among the elderly cause considerable public 
health concern, particularly in populations that have growing numbers of older adults.  In 
North America, the prevalence of dementia has been estimated between 6 and 10 percent 
of adults aged 65 years and older, with nearly two-thirds of all dementia cases diagnosed 
as Alzheimer’s disease (AD).1-5  The prevalence of both all-cause dementia and AD rise 
dramatically with age, increasing from below an estimated 3 percent for those aged 65-
74, to approximately 11 percent between ages 75-84, to over an estimated 30 percent in 
persons aged 85 years and older.1-3  Mild cognitive impairment, considered a state of risk 
for dementia and Alzheimer’s disease, has also been measured in the community using 
different diagnostic criteria at a prevalence between 3 and 19 percent, with an estimated 
conversion rate to dementia of 11-33 percent over two years.6, 7  Etiologic factors that 
could be targeted for primary prevention, or that could aid in an understanding of the 
etiology of clinical presentation, are being widely studied.  Among them, the study of 
individual capacity to avoid the symptoms of dementia or cognitive impairment during 
life has gained significant attention in the literature, largely in the field of Alzheimer’s 
disease. 
The concept of individual brain reserve originated from autopsy studies of 
Alzheimer’s disease, where it was observed that individuals may meet the criteria for 
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neuropathologic AD at autopsy, even at very old ages, without having manifested 
symptoms of cognitive decline.8-12  These observations led to hypotheses regarding the 
individual differences in apparent tolerance for the pathology resulting in the 
maintenance of relatively normal functioning.   
The specific idea of brain reserve was posed following one such autopsy study, in 
which the observed differences between the demented and cognitively normal included a 
higher brain weight and greater number of large neurons at autopsy of the non-demented 
individuals.8  A hypothesis of brain reserve was formalized,13 stating that individuals may 
possess more neural substrate (larger brains) and redundant neural networks that allow 
for normal cognition in the presence of neuropathology.  Conversely, those with small 
head sizes and therefore smaller brains may be at greater risk for cognitive decline given 
the same pathology.   
The brain reserve hypothesis and its role in a threshold model of dementia were 
further specified by Mortimer.14, 15  In this model, clinical expression of dementia in the 
individual is dependent both upon a propensity to accumulate pathological lesions and 
upon the attainment of a critical threshold of neural reserve below which normal 
cognition can no longer be maintained.14  Risk factors for neuropathology and for clinical 
expression may therefore be considered separately.  In Alzheimer’s disease, for example, 
risk factors for neuropathology include genetic predisposition, Down’s syndrome, head 
injury, diabetes, and cardiovascular and cerebrovascular conditions.  Clinical expression, 
on the other hand, may be dependent upon brain development, body growth, early-life 
socioeconomic conditions, income, education and IQ.16, 17  
5 
The risk factors for clinical expression, as opposed to those for neuropathology, 
are contributors to the unified concept of brain reserve.  In clarifying this concept, 
Mortimer stipulated that reserve could assume any of three forms: the number or density 
of neurons attained in adolescence, the collection of cognitive strategies and test-taking 
abilities (akin to cognitive reserve, discussed below), and the amount of functional brain 
tissue at any age.15  Individual differences in these three subtypes of brain reserve, 
combined with individually-determined rates of pathological accumulation, influence the 
trajectory of descent toward the threshold, resulting in earlier clinical presentation of 
abnormal cognition for those with smaller maximal attained brain size, fewer cognitive 
strategies, and faster rates of accumulation.  The current study aims to identify whether 
smaller attained brain size increases the risk of poor cognitive performance in an analysis 
that controls for both individual cognitive ability and a predictor of the rate of 
accumulation of Alzheimer pathology in a community sample.  This analysis will use 
head circumference, pre-morbid IQ and genetic predisposition to Alzheimer’s disease as 
proxy measures, respectively, for the three conditions under which cognitive decline is 
hypothesized to clinically manifest.   There is also an interest as to whether the 
predisposition toward faster rates of accumulation interacts with smaller attained brain 
size to modify the association between head size and cognitive performance.  
Prior to reviewing the literature investigating the associations between head size 
and cognition, it may be informative to discuss the determinants of head size 
measurements.  The growth of the cranium is driven by brain growth achieved during 
childhood.16  It is known that both brain weight and intracranial volume achieve at least 
75% of their maximum size by the age of three and achieve adult size by age 15.18, 19  
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Brain growth is largely dependent upon genetic and environmental factors, although the 
extent of separate influence from these factors is unclear.  For example, it has been 
observed that poor nutrition leads to delayed or abnormal brain development not 
amenable to catch-up growth17, 20.  It has also been found in animal studies that an 
enriched environment increases brain weight and dendritic branching.21  Additionally, 
secular increases in brain size have been noted in developed countries,14, 22 furthering the 
case for the role of environment in brain growth.  On the other hand, twin and family 
studies indicate a potentially large role for genetic, as compared to environmental, 
contribution.  Estimates of the genetic influence on head size have placed heritability of 
intracranial volume at roughly 80%23 and of head circumference at close to 60%.24  
Nevertheless, the authors caution against the possibility that these heritability estimates 
may be inflated, citing the difficulty in the separation of environmental and genetic 
factors of influence.  It is possible, therefore, that both environmental and genetic factors 
play substantial roles in the growth of the brain, and thus attained head size.  
Most of the research on estimates of maximal attained brain size with cognition 
has generated consistent support for the brain reserve hypothesis.  Several studies have 
found a consistent association between head circumference and measures of cognition 
among those diagnosed with dementia.25-27  In one of the earliest studies examining a 
large (n=1985) population-based sample of Japanese-Americans in King County, 
Washington for prevalent dementia (Kame Project), a significant association (p=0.006) 
between head circumference and Cognitive Abilities Screening Instrument (CASI) scores 
was found among those diagnosed with AD.25  It was found that scores among those 
patients with lower HC were worse than those among patients with higher HC, an 
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association that was not seen among non-demented individuals.  Another study 
examining a hospital-based sample of AD patients in Japan found that intracranial 
volume (ICV), a measure of maximal brain size, was correlated between 0.289 and 0.396 
(p<0.05) with several measures of intelligence, including the Wechsler Adult Intelligence 
Scale-Revised (WAIS-R) and Raven’s Colored Progressive Matrices (RPM).26  A third 
and more recent study identified a statistically significant correlation of 0.33 (p=0.01) 
between ICV and MMSE scores among those with AD and VaD.27  The same study, 
using linear regression, found that a 66.7 cm3 increase in ICV was associated with a 1-
point change in MMSE, adjusted for age and gender. 
Compelling evidence in support of the brain reserve hypothesis has come from 
studies that compare cognitively impaired subjects with normal controls.  Schofield et al. 
found, for example, that head circumference in the lowest gender-specific quintile, 
compared with the other four quintiles, was associated with increased prevalence of 
probable and possible AD with an OR (95%CI) of 2.9 (1.4, 6.1) in women and 2.3 (0.6, 
9.8) in men.28  Wolf et al. examined ICV across normal controls and patients with 
prevalent mild cognitive impairment (MCI), AD and vascular dementia (VaD).29  The 
authors found a decreasing prevalence of cognitive impairment among increasing 
quartiles of ICV (chi-square statistic for linear trend = 8.5, df=1, p=0.003).  Later work 
by Wolf et al. on a different population demonstrated an increased risk of cognitive 
impairment [OR: 2.8 (1.3, 6.0)], including MCI, and of dementia [OR: 2.5 (1.2, 5.1)] for 
ICV in the lowest quartile compared to the top three quartiles.27  Additionally, Mortimer 
et al. found in a study of 294 Catholic sisters that head circumference in the lower two 
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tertiles and low education (<16 years) interacted to substantially increase the risk of 
prevalent dementia [OR: 4.3 (1.9, 9.6)].30   
A third line of research on the role of brain reserve in the timing of clinical 
presentation has generated slightly less consistent results.  Several studies have found 
strong inverse associations between time to onset of cognitive impairment and head size.  
Schofield et al., in a study of 28 female AD patients from a New York clinic, found that 
age at first symptom onset was significantly correlated (r=0.64, p=0.01) with a cross-
sectional measure of intracranial area.31  In the follow-up phase of the Kame Project, 
mentioned previously, two subsequent analyses revealed head circumference as an 
important risk factor for incident AD among those at genetic risk for the disease, defined 
as possession of one or more APOE ε4 alleles.32, 33  The first analysis found that head 
circumference in the lowest tertile (<21.4 inches) combined with positive ε4 status 
predicted earlier onset of incident AD at a hazard ratio (HR) of 14.1 (3.0-65.0), adjusted 
for gender and education.32  The second analysis found that developmental variables 
including small head circumference (≤ 54.4 cm, or 21.4 inches) and having four or more 
children in the household at age 2-3 years were independently predictive of earlier onset 
of AD among ε4-positive subjects, while vascular risk factors were more important 
among ε4-negative individuals.33  These findings illustrates the importance of reserve 
factors (e.g. HC) in delaying clinical presentation of disease among those individuals who 
may be at genetic risk for faster accumulation of pathology. 
There have been a few studies that have not found evidence that pre-morbid brain 
size protects against cognitive decline.  In one case-control examination of familial (early 
onset) and sporadic (late onset) AD, no difference was found in mean ICV across groups, 
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controlling for age, education and gender.34  The author also found that ICV, the 
dependent variable in a linear regression, did not differ by age or age at onset of 
symptoms, although the approach of adding an indicator of dementia type (familial or 
sporadic) to the model may have offered less than ideal control for this factor without 
stratified analysis.  Furthermore, it is possible that findings may have varied had the 
authors examined the range of risk (lowest quantile) instead of continuous ICV.   
A second analysis by Edland et al. with more thorough control of potential 
confounders and examination of both tertiles and continuous ICV in a case-control study 
of 166 subjects with and 184 subjects without AD found no significant difference in 
mean ICV between patients and controls, accounting for age, education, APOE ε4 status, 
and birth year.35  ICV in the lowest tertile did not predict AD for men or women, and age 
at onset was not correlated with ICV.  Although the study appears well-controlled, the 
population in which this study was conducted tended to be a well-educated sample36 and 
the author cited the limitation that adverse developmental conditions (leading to reduced 
adult brain size) probably were not common among the sample.  It is possible, therefore, 
that there were insufficient numbers of individuals with small ICV.  Additionally, it was 
unclear whether the authors specified the lowest tertile in a gender-specific manner, as 
did Wolf et al. and Schofield et al. mentioned above.27-29  Analyses from the Kame 
Project, which similarly found no mean difference of HC between cases and non-cases, 
also did not specify HC in a gender-specific fashion.25, 32, 33  Given likely differences in 
brain structure and function in men and women,37 specification of the gender-specific 
range of risk in head size may be subject to less bias from misclassification and may 
result in more valid measures of risk.  Gender-specific quantiles also help to overcome 
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problems of collinearity between gender and head size in modeling, such as those 
encountered in the Kame analysis.33  It is unknown as to the extent to which these issues 
may have contributed to the null finding in the results presented in Edland et al.35
The most recent study to produce null findings provided both a large-scale case-
control analysis and a longitudinal follow-up of 450 non-demented controls examining 
head circumference and time to conversion to AD.38  This study found no mean 
difference in HC across case-status in the case-control analysis and no association 
between either continuous HC or the lower gender-specific quartile of HC and time to 
conversion to AD, although the sample size and relatively few conversion events may 
have limited the prospective analysis.  The analyses were adjusted for age, APOE ε4 
status, family history of AD, gender and education.  While there are many strengths to 
this study in addressing some of the analytic concerns, findings in previous analyses of 
time-to-AD with head size as a predictor33 indicate the importance of stratifying results 
by APOE ε4 status to examine reserve while ‘controlling’ for genetic predisposition 
toward faster decline. 
Examining the reserve hypothesis more generally, several studies have found 
associations between head size and cognitive outcomes, particularly cognitive decline, 
among non-demented and community-living individuals.  Among the first to do so, 
Reynolds et al. examined head size and MMSE scores in a community-based survey of 
the MoVIES cohort (n=852), which followed initially non-demented subjects of mostly 
Caucasian background with relatively low socioeconomic status from 1993 until 1996.39  
In a baseline analysis, and using gender-stratified logistic regression with low MMSE 
(≤10th percentile) as the dependent variable, each 1-centimeter increase in HC was 
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inversely associated with low MMSE scores [OR (95%CI) women: 0.83 (0.69, 0.99); OR 
men: 0.79 (0.63, 0.98)].  A similar finding was observed by Tisserand et al. in a baseline 
examination of multiple cognitive outcomes with HC among initially non-demented 
adults.40  In that study, increasing continuous HC adjusted for age and gender was 
significantly and positively associated with continuous MMSE scores and several 
measures of intelligence using the Groningen Intelligence Test, adjusted for gender, sex, 
and either height, socioeconomic background or educational level. The authors also 
found significantly increased time to completion of the Stroop Color-Word task, scored 
so that longer times indicate slower processing speeds, with lower HC.40   
A third study also confirmed the association between adult head size and 
cognition, finding that mean intelligence scores as measured by the AH4 test at two test 
periods 3.5 years apart in a sample with a mean age of 70 years increased with increasing 
quartile of HC (p for trend <0.01 at both trials, adjusted for age, sex, education, social 
class at birth, history of cerebrovascular disease, and health profile emotional scores).41  
Conversely, no such trend was observed for cross-sectional measures of immediate and 
delayed memory measured by the Logical Memory Test, an observation replicated by 
Tisserand et al., though there was a trend toward decline in immediate recall (p=0.03) and 
delayed recall (p=0.07) over time for those with smaller head circumferences.40, 41
Finally, two studies examined the association between ICV and cognition with 
inconsistent results.  One study comprehensively measured both ICV and regional brain 
volumes in 97 healthy, non-medicated men with a mean of 68 years of age.42  ICV 
correlated with measures of pre-morbid intelligence (National Adult Reading Test, 
r=0.304, p<0.005; Raven’s Standard Progressive Matrices (RPM), r=0.39, p<0.000) and 
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visual memory, but not immediate or delayed verbal memory (from the Auditory Verbal 
Learning Test, or AVLT, among others).  The second study measured ICV and cognitive 
functioning also using RPM and AVLT in a sample of healthy men born in 1921, aged 79 
years, finding no association between the ‘passive’ reserve represented by ICV.43  The 
measure was adjusted for intelligence scores measured at age 11, measures of brain 
burden by number of white-matter hyperintensities, age and sex.  A comparison between 
the studies is made very difficult by the differences in adjustment and subject age: 
whereas the former study did not make adjustments for other factors, the latter study 
more rigorously explored the reserve hypothesis by controlling for pathological burden 
and childhood intellectual function, which may provide a “cognitive reserve” in terms of 
more flexible or efficient networks that may protect against decline in lieu of brain 
reserve.43, 44  However, the statistical adjustment and inclusion of childhood IQ in the 
study by Staff et al. may have weakened the association to the extent that it was 
undetectable in that sample.  Additionally, the much older subjects in that study may have 
been selected by survival to have slower rates of accumulated pathology and less effect of 
head circumference, as was suggested in the Kame Project analyses above.  
Unfortunately, no data on APOE ε4 status was available for either study, rendering 
further speculation about the effect of genetic risk for AD pathological accumulation 
impractical. 
The consideration of APOE ε4 status as a proxy for accumulated pathology and of 
pre-morbid intelligence as a measure of cognitive reserve is important in the study of the 
reserve hypothesis.  Cognitive reserve has been proposed as a complementary means of 
explaining the disparity between sufficient pathological accumulation and clinical 
13 
presentation of dementia under the reserve hypothesis.44  It states that those individuals 
possessing more efficient and flexible cognitive networks may compensate for pathology 
more successfully during life than those who do not have such networks.  Staff et al. and 
Mortimer et al., among others mentioned previously, have used measures of pre-morbid 
(i.e. pre-decline, whether age-related or pathological) intelligence and/or education level 
as a proxy for such reserve.30, 43  Most commonly, the measure of adjustment is 
education, given a known association with head size29, 35, 40 and with cognitive 
measures,45, 46 although pre-morbid intelligence measures may be a more sensitive 
individual measure of cognitive reserve.47, 48  Diverse measures of increasing physical 
reserve, such as physical activity in youth, height and limb length, which may indicate a 
type of robustness against decline in age, have also been demonstrated to have an inverse 
association with cognitive decline.49-53  None of the studies of physical reserve, however, 
have accounted for the correlation between body measurements and head size. 
Consistent adjustment for these measures of burden and reserve have been absent 
in studies of head size with cognitive impairment or decline.  While measures of 
cognitive reserve are often controlled for in analyses with demented subjects, it has 
produced inconsistent results among the cognitively normal.  Adjustment for height and 
APOE ε4 status has also been sporadic in the literature, even though the substantial 
findings involving these measures indicate a need to consider them as standard potential 
confounders in the study of cognitive decline.  In the current analysis, head size as 
measured by HC is compared with eight cognitive outcomes in a sample of community-
living older adults.  Both APOE ε4 status and height, along with education and a measure 
of pre-morbid IQ,54 are considered as potential confounders, and data are examined for 
14 
potential effect modification by APOE ε4 status.  BMI is also included among the 
covariates as a convenient, though imprecise, proxy for potential risk from vascular, 
diabetic or metabolic syndrome factors.55, 56
  The main hypothesis being tested is that small head circumference, determined 
in a manner that includes the gender-specific range of risk, is associated with a greater 
odds of poor cognitive outcome among subjects in the community.  The secondary goal 
of the analysis is to test for effect-modification by APOE ε4 status in any association 
found between head circumference and cognitive outcome.  Literature support and 
applicability of the hypothesis to the specific cognitive outcomes analyzed in this study 
will be discussed in further detail in the Discussion chapter.   
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Chapter 3 
Methods 
Design and Population 
 This study analyzes secondary data from the Charlotte County Healthy Aging 
Study (CCHAS), a cross-sectional study of primarily Caucasian community-living older 
adults in Charlotte County, Florida.  Two census tracts from this region were selected for 
CCHAS based on information from the 1990 U.S. Census that indicated it contained the 
highest proportion of residents aged 65 and older in Florida.  One tract contained 7,093 
inhabitants in 1990 (45.2% aged over 65 years), and the other contained 6,233 inhabitants 
in 1990 (37.4% over 65 years).  Census blocks were sampled consecutively from a 
randomly ordered list obtained for each of the two larger census tracts.  Prior to 
recruitment, a large-scale publicity campaign generated support for the study through 
newspaper articles, presentations to community organizations, local television and radio 
appearances, and the formation of a Community Advisory Council of 12 community 
leaders.57   
Eligible subjects were identified by canvassing all households, documenting all 
addresses within each block, and then revisiting the blocks at different times on different 
days to request household information on name, age and sex of all persons in residence.  
Unreachable households were those that did not answer the door after two attempts.  A 
stratified sampling procedure was used within the selected census blocks until the desired 
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sample size was reached.  The final sample was to contain approximately equal 
proportions of male and female participants, a total of 126 persons within each of two age 
strata: age 60-74 and 75-84.57, 58  The sampling method was also modified slightly to 
facilitate obtaining as representative a sample as possible of the independently living 
elderly population of Charlotte County (for example, by including all members on each 
side of a street when a census block divided them). 
Of 4017 households surveyed in the selected tracts, census data were obtained for 
2164 (54%) in the first phase of the study.  From these, 1394 subjects were identified as 
eligible and invited to participate via postal mail and follow-up telephone calls, including 
multiple eligible subjects per household.  Of those eligible, 584 (42%) were unreachable, 
defined as no answer to up to nine telephone attempts at contact.  Of those eligible and 
reachable, 468 participated in the study, 306 refused, and 36 accepted and later declined.  
From age, gender and education data on a portion of those who refused or did not 
complete all phases, it was determined that those who completed all phases were 
comparable to those who did not.  Refusers were similar in age to completers, were more 
likely to be women and to have less education (p<0.05).  Sampled participants were 
primarily Caucasian (>98%).57, 58
 
Measures 
CCHAS Procedures 
 Exposure, outcomes, and potentially confounding and/or modifying variables for 
each subject were assessed during two personal, structured interviews conducted over 
approximately one week, both in the homes of the subjects or at a neutral location 
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according to subject preference.58  Income and years of education were assessed during 
the first interview, in which trained personnel administered a risk factor questionnaire.  
Interviewers recorded physical measures, including head circumference (HC), weight and 
height, and assessed cognitive outcomes during the second interview one week later.  
Blood samples were collected by a phlebotomist during the week between the two 
interviews.  The phlebotomist visited the subject’s home, where blood samples were 
taken to measure cholesterol levels, A1C levels for diabetes, folate, and to obtain DNA 
for genotyping of APOE.  All data were collected between November 1, 1997 and June 
30, 1998.  Procedures for CCHAS were approved by the University of South Florida 
Institutional Review Board and written informed consent collected for each participating 
subject. 
Variables 
Head Circumference.  Head circumference (HC) is the primary exposure of 
interest in the current analysis.  HC was measured by placing a non-distensible, flexible 
measuring tape at the line of the eyebrows and passing it snugly around the outermost 
occipital protuberance, returning to the eyebrows.   HC was measured in inches for each 
subject and rounded to the nearest ¼ inch.32  
Cognitive Outcomes.  The following defines the eight cognitive outcomes of 
interest.  All outcomes were dichotomized as described in the section on Bivariate 
Statistics in the Methods. 
a. The Modified Mini-Mental State Examination: The 3MS is a standardized 
measure of general cognitive ability in which the subject is asked a series of 
18 
questions. It samples a range of cognitive functions and the total score, used 
for this analysis, is scaled from 0 to 100.59 
b. Memory subscales of the Hopkins Verbal Learning Test-Revised (HVLT),60 
including Immediate Recall (ImR), Delayed Recall (DeR), Cued Recall (CuR) 
and Recognition (Cite Small here):  For each of the four measures, a word list 
of 12 words was used.  For ImR, there are three learning trials, and the 
number of words remembered immediately after each trial is recorded and the 
three totals summed.  For DeR, the subject is asked to remember the list in the 
three trials of free recall after an interference test; the total number of words 
recalled for each trial are summed.  In the CuR subsection, administered 
directly after the DeR subsection, the subject is asked to recall the words 
according to the category they belong to.  There are three categories, and the 
numbers of words recalled in each category are summed for a total cued score.  
The score used in this analysis is the gain from cues, measured as the DeR 
score subtracted from the summed total cued score.  Finally, the subject is 
read a list of 24 words including the 12 they were asked to remember, and is 
asked to respond as to whether or not the word read was on the original list of 
12.  The correct and incorrect positive responses are summed, and the 
incorrect positive responses are subtracted from the correct positive responses 
to yield a discrimination index score representing Recognition. 
c. Stroop Color-Word Test61 (Stroop): In this test, the subject is asked to read 
from three panels containing, respectively, words referring to colors (e.g. 
Blue), only colors with no words, and mismatched color-word combinations.  
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The score used in this analysis is the number of words completed on the color-
word task within a time limit. 
d. Trail-Making Test, Parts A and B62 (Trails): In these tests, subjects are asked 
to draw a line trail through randomly scattered bubbles containing numbers 
only (Part A) or numbers and letters (Part B) in sequential and 
sequential/alphabetical order, respectively.  The score used for this analysis is 
the difference between the amount of time it took for the subject to correctly 
finish Parts A and B.   
e. Implicit Memory63 (Implicit): For this test, the subject was asked to read a 
word list containing nonsense and real words and to identify the real words.  
After an interference test (Trails), the subject was asked to complete word 
stems.  Half of the stems were from real words they had seen on the previous 
task.  The score used for this analysis, the priming score, is the total number of 
stems completed with words subjects had seen before minus the total number 
of stems completed with words not seen before.   
Other Variables of Interest.  Age was measured as the age at examination and 
calculated using SAS variables for the unique dates of examination and birth.  Education 
was measured as the number of formal years of regular school completed, as reported by 
the subject.  Income was scored as an ordinal variable representing nine levels of annual 
household income from “below $10,000 per year” (Level 1) to “above $150,000 per 
year” (Level 9).  Scales to measure height were calibrated to one another and taken into 
the field.  Height was measured against a wall and was in inches, rounded to the nearest 
¼ inch.    BMI was calculated as the weight in kilograms of the subject divided by the 
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squared height in meters.  Pre-morbid intelligence was assessed using a standard 
measure, Spot The Word Test 1.54  In this test, participants are asked to identify the real 
words in a list of 60 word pairs containing one real and one nonsense word.   Each 
correctly identified word earns one point, with a maximum score of 60.  Higher scores 
indicate higher crystallized intelligence, an indication of higher pre-morbid intelligence. 
APOE Genotype 
Blood samples were prepared by separating leukocytes from whole blood and 
lysing the cells using prepared stock solutions.  The DNA was extracted by centrifugation 
and washed with ethanol before resuspension in tris-EDTA acid buffer solution.  APOE 
genotyping was performed using standard digestion and PCR amplification.57, 58  From 
the dual-allele genotype, APOE status was dichotomized as an ε4 allele being present or 
absent, defined in the methods of analysis below. 
 
Analysis 
All analyses were performed using the SAS Statistical Software package, version 
9.3.  
Univariate Statistics 
Histograms were generated to visually assess the distribution of each continuous 
variable, and the mean and standard deviation of each was calculated to describe central 
tendency and dispersion.  Means and standard deviation for the exposure measure, HC, 
were also stratified by gender, and tested for difference in means using a t-test for 
independent means.64  For categorical variables, frequency and relative frequency were 
calculated to describe distribution across levels. 
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Defining the Variables for Analysis 
 The exposure variable, HC, was first stratified by gender and then frequency, 
relative and cumulative relative frequencies for each ¼-inch interval were examined 
across the entire range.  This was done to identify an acceptable dichotomization point 
that would accurately reflect the range of risk by gender in this sample. Once an 
appropriate point was identified, male and female subjects were classified by their 
exposure status separately then combined within a single dichotomous variable.  
Outcomes were also dichotomized.  Those subjects with scores falling at or below the 
bottom 20th percentile were classified as having a poor outcome, as compared with 
normal outcomes above the bottom 20th percentile.  (Note: For Trails, the absolute value 
of the difference was scored, where larger differences indicated a poor outcome, therefore 
scores falling at or above the top 20th percentile were classified as a poor outcome.)  Two 
exceptions, CuR and Implicit memory, were dichotomized at the interval directly below 
that in which the 20th percentile resided due to a small range and tight clustering about 
the mean.  Body Mass Index was dichotomized as obese and non-obese, using a BMI of  
≥ 30 to indicate obesity.65  All other covariates, except gender and APOE, were kept as 
continuous variables.  APOE status was described as either possessing one or more 
APOE ε4 alleles (ε4-positive) or possessing no ε4 alleles (ε4-negative). 
Bivariate Analysis 
 Logistic regression was performed and crude odds ratios, 95% confidence 
intervals, and p-values were generated for each outcome with exposure, and for each 
outcome with each covariate.  For each outcome with the exposure, the crude association 
was also analyzed stratified by gender.  Logistic regression was then performed for the 
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exposure with each covariate.  Those variables having associations reaching a 
significance of p ≤ 0.10 with both the exposure and outcome were considered as potential 
confounders.  Concomitant predictors of outcome also were identified.  All odds ratios 
are reported for the odds of low head circumference (exposed), poor outcome, increasing 
value (continuous covariates), being female (Gender), obese (BMI) and ε4-positive 
(APOE). 
Multivariate Analysis and Modeling 
 The main objective of the multivariate analysis was to identify the most 
parsimonious model that described the odds ratios for the eight outcomes as they related 
to head circumference.  The approach taken was to illustrate the crude, standard-adjusted, 
fully-adjusted, and trimmed models.  The standard-adjusted model contained those 
variables most consistently identified as potential confounders and used as model 
variables in the literature: age, gender and years of education.  The fully-adjusted model 
contained all confounding variables and concomitant predictors identified for each 
outcome at the specified significance within this sample.  The trimmed model, accepted 
as the final model for each outcome, was identified by a manual backwards selection 
procedure for those HC-Outcome associations reaching significance at p<0.05 in the full 
model.  In this procedure, variables were removed singly from the full model and the 
effect of their removal was ranked in terms of percent change in the point estimate of the 
exposure.  The least change earned a value of one, the next largest change two, and so on.  
Variables were then removed sequentially from the full model in order of rank until a 
noticeable (10%) difference in the point estimate from the full model was observed.  The 
model analyzed just prior to the noted change in estimate was selected for analysis of 
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potential joint confounders, which were added if found, completing the final model.66  In 
the instance that no statistically significant association was observed between head 
circumference and the outcome, the fully adjusted model was accepted over the crude as 
the final model.  Although no inference can be drawn from either model, the fully 
adjusted model was chosen as final over the crude in these non-statistically-significant 
instances primarily so that the final model could reflect the best-fitting model as indicated 
by the Likelihood Ratio statistic. 
All model summaries list odds ratios, 95% confidence intervals, and p-values for 
the models as calculated both with the total sample and stratified by gender.  Final 
models were analyzed for fit using the Hosmer-Lemeshow Goodness of Fit test.67
Interactions 
 All final models were analyzed for interaction using logistic regression by 
reintroducing the main effect term for APOE where necessary and adding a term for the 
interaction between the exposure variable and APOE status to each final model.  
Interactions were accepted as potentially inferential at a significance of p ≤ 0.1.  A post 
hoc analysis of model fit was completed separately for the addition of APOE and the 
interaction term, and the data were also examined further for potential interaction by 
analyzing the two-by-two tables for outcome and HC stratified by APOE status. 
  
 
Chapter 4 
Results 
Descriptive Analysis 
A histogram (not shown) for each continuous variable of interest was generated in 
order to characterize their distributions in this sample.  All continuous variables displayed 
a roughly normal distribution with little skew, implicating the mean and standard 
deviation as acceptable measures of central tendency and dispersion.  Results of the 
univariate analysis of continuous variables are found in Table 1a and 1b.  The frequencies 
and relative frequencies of gender and APOE status are found in Table 1c.  There was a 
significant difference in the mean head circumference by gender (t-test p<0.0001), 
indicating the need to examine the range of risk stratified by gender. 
M 22.7 ( 0.7 ) 73.5 ( 6.2 ) 14.6 ( 3.2 ) 4.4 ( 1.5 )
F 21.6 ( 0.6 ) 72.6 ( 6.3 ) 13.2 ( 2.7 ) 3.9 ( 1.6 )
All 22.2 ( 0.8 ) 73.0 ( 6.2 ) 13.9 ( 3.0 ) 4.2 ( 1.6 )
M 49.7 ( 6.2 ) 68.9 ( 3.4 ) 28.4 ( 4.6 )
F 49.3 ( 5.9 ) 62.9 ( 2.8 ) 26.9 ( 5.8 )
All 49.5 ( 6.0 ) 65.8 ( 4.3 ) 27.6 ( 5.3 )
Mean (SD)
Mean (SD)
IQ Height BMI
Table 1. Descriptive Measures for HC, Covariates and Outcomes
Table 1a.  Mean and Standard Deviation for Continous HC and Covariates
HC Age Education Income
 
24 
91.6 ( 7.6 ) 20.1 ( 5.5 ) 7.5 ( 2.8 ) 1.0 ( 1.6 )
9.5 ( 2.0 ) 28.1 ( 9.6 ) 74.8 ( 57.6 ) 2.1 ( 2.7 )
Trails Implicit
Mean (SD)
Mean (SD)
Recog. Stroop
Table 1b.  Mean and Standard Deviation for Continous Outcomes
3MS ImR DeR CuR
 
228 ( 49 ) 240 ( 51 ) 360 ( 78 ) 102 ( 22 )N (%)
Table 1c.  Frequency and Relative Frequency for Gender and APOE Status
Gender APOE
Male Female ε4 Neg ε4 Pos
 
 
 
Bivariate Analysis 
After stratifying by gender and examining the frequencies across the range of HC 
for each stratum, it was determined that using the interval in which fell the exact bottom 
tertile, quartile or quintile (standard levels of comparison in the literature) would not 
allow sufficient diversity between the dichotomized levels to ensure that the “low” 
classification was capturing risk. Therefore, the interval directly below that which 
contained the bottom 20th percentile was chosen as the appropriate point at which to 
dichotomize the variable.  As Table 2 illustrates, this created an exposed group 
containing 5.8 percent of the sample.  Table 2 also shows the relative frequency across 
levels for outcomes and BMI after dichotomizing in the interval of the bottom 20th 
percentile for outcome and at or above 30 (obese) for BMI.  CuR and Implicit outcomes 
show that slightly less of the sample, 12.6 and 19.2 percent respectively, was classified as 
a poor outcome for those variables. 
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L H L H L H L H L H
N 27 441 101 367 99 369 103 365 59 409
% 5.8 94.2 21.6 78.4 21.2 78.9 22.0 78.0 12.6 87.4
L H L H L H L H O NO
N 128 340 98 370 101 367 90 378 121 347
% 27.4 72.7 20.9 79.1 21.6 78.4 19.2 80.8 25.9 74.2
* L: Low     H: High/Normal     O: Obese     NO: Non-obese
Recog. Stroop Trails Implicit BMI
Table 2.  Frequencies and Relative Frequencies of Dichotomized Variables
HC 3MS ImR DeR CuR
 
Appendix A shows the results of all crude logistic analysis for the exposure with 
outcomes (Table A1), and for covariates with both exposure and outcome (Tables A2 and 
A3).  In crude analysis, HC was significantly associated at p ≤ 0.001 with 3MS 
[OR(95%CI): 4.38 (1.99, 9.66)], an association that persisted for both sexes when 
stratified by gender [Male OR: 3.09 (1.07, 8.96); Female OR: 6.58 (1.99, 21.8)].  HC did 
not approach statistical significance for any other outcome.  Larger HC also was 
statistically significantly associated with more years of education [OR for low HC with 
increasing number of years of education: 0.86 (0.76, 0.98); p=0.02], increasing height 
[OR: 0.91 (0.83, 1.00); p=0.05] and most significantly increasing IQ [OR: 0.92 (0.87, 
0.98); p=0.004]. There were also non-significant associations (p=0.09) of HC with the 
possession of an APOE ε4 allele [OR: 0.28 (0.07, 1.21)], which may suggest that 
individuals with higher HC were more likely to possess an APOE-e4 allele in this 
sample, and with increasing age [OR: 1.06 (0.99, 1.13)], suggesting that individuals with 
smaller HC tended to be somewhat older than those with larger HC. 
Confounders and concomitant predictors were identified for each outcome using 
Tables A2 and A3.  Table A2 shows the confounders and their associations for each 
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outcome, associated with both outcome and HC at p ≤ 0.1.  Concomitant predictors (T) 
and confounders (C) for each outcome are summarized in Table 3 in the Full Model (F).  
No confounders or predictors were identified for CuR.  
 
Multivariate Analysis 
The resulting odds ratios and corresponding confidence intervals for poor 
outcome with exposure to low HC can be seen in Table 3 for the crude, standard-
adjusted, full and trimmed models.  All final models demonstrated good fit with the 
Hosmer-Lemeshow test for goodness of fit.  These results, as well as the results of the 
final model selection process, are presented below by outcome: 
3MS (Table 3a) 
  After adjustment for standard and full-model variables, the estimate of the OR 
was reduced slightly from 4.38 to 2.96, but remained significant (p=0.03).  From the 
stratified results of the full model we see that while the OR for men remained 
consistently above 2, the OR for women was higher [4.35 (1.00, 18.9)], reaching 
significance at p=0.05.  Model selection procedures (MSP) revealed education and 
income as variables with little impact on the exposure-outcome association in the model.  
Removal of both resulted in a slightly higher odds ratio for all three estimates, and greater 
significance in the total sample and male subsample (Model 5).  The change in estimate 
for the total sample was less than 10% of the unstratified full model, the previously 
identified criterion for allowing removal of the variable, but considerably changed the 
estimate in males.  Income was identified as the variable responsible for the large change, 
a predictor variable that showed more potential as a confounder in men than women 
(Appendix A, Table A3).  Income was therefore reintroduced to produce a more 
conservative final model (Model 4).  The final estimate, adjusted for age, education and 
income, was nearly identical to the full model and had a slightly smaller confidence 
interval [OR: 2.97 (1.12, 7.89)].  Given that only education was removed during the 
MSP, assessment for joint confounding was not necessary for this outcome. 
 
N OR ( ) p
1 468 4.38 ( 1.99 , 9.66 ) <0.0001
2 462 3.37 ( 1.40 , 8.11 ) 0.01 X X X
3 F 421 2.90 ( 1.09 , 7.71 ) 0.03 C C T C
4 * 421 2.97 ( 1.12 , 7.89 ) 0.03 C T C
5 463 3.11 ( 1.18 , 8.25 ) 0.02 C C
I 417 C T C R I
IQ H
ei
gh
t
A
PO
E
A
ge
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n
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r
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e
Table 3. Model Selection for Main Effect of Head Circumference and APOE 
Interaction 
No interaction observed**
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.99)
A
PO
E*
H
C
OVERALL
Model 95% CI
Table 3a.  Model Selection for HC with 3MS
HC
N OR ( ) p OR ( ) p
1 468 3.09 ( 1.07 , 8.96 ) 0.04 6.58 ( 1.99 , 21.8 ) 0.002
2 462 2.36 ( 0.69 , 8.07 ) 0.17 5.25 ( 1.40 , 19.6 ) 0.01
3 F 421 2.00 ( 0.51 , 7.84 ) 0.39 4.29 ( 1.00 , 18.4 ) 0.05
4 * 421 2.04 ( 0.52 , 7.94 ) 0.31 4.51 ( 1.03 , 19.7 ) 0.05
5 463 2.46 ( 0.64 , 9.01 ) 0.17 4.60 ( 1.02 , 20.8 ) 0.05
*Final Model     F: Full Model    
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
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ImR (Table 3b)   
The crude association between low HC and poor outcome showed an initially 
positive direction [OR (95%CI): 1.62 (0.69, 3.82); p=0.27; Model 1], but after both 
standard and full adjustment the OR moved toward the null and showed no significant 
association between exposure and poor outcome (Model 3).   
 
N OR ( ) p
1 468 1.62 ( 0.69 , 3.82 ) 0.27
2 462 1.05 ( 0.40 , 2.76 ) 0.92 X X X
3 *F 419 1.09 ( 0.37 , 2.94 ) 0.94 C C T T C C
I 456 C C T T C C R I
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.50)
OVERALL
Model 95% CI
No interaction observed**
Table 3b.  Model Selection for HC with ImR
HC
A
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A
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C
 
N OR ( ) p OR ( ) p
1 468 1.37 ( 0.45 , 4.18 ) 0.58 1.90 ( 0.49 , 7.39 ) 0.35
2 462 0.83 ( 0.22 , 3.06 ) 0.78 1.33 ( 0.33 , 5.44 ) 0.69
3 *F 419 0.73 ( 0.17 , 3.13 ) 0.67 1.51 ( 0.33 , 6.88 ) 0.60
*Final Model     F: Full Model     
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
DeR (Table 3c)   
Though the crude OR for delayed recall showed a positive direction initially, 
standard and full adjustment changed the direction of the association for the total sample 
(Models 2 and 3).  No associations were found to be statistically significant, therefore no 
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selection procedures were performed.  The male subsample showed a consistently 
positive direction in all adjusted models, but also highly insignificant (p=0.68).  In 
women, the crude direction of association was negative and continued to drop and gain 
significance with adjustment, resulting in an OR (95%CI) = 0.37 (0.06, 2.19) at p=0.28 in 
the final model. 
N OR ( ) p
1 468 1.53 ( 0.65 , 3.61 ) 0.33
2 462 0.96 ( 0.36 , 2.52 ) 0.93 X X X
3 *F 416 0.80 ( 0.28 , 2.29 ) 0.67 C C T T C C
I 416 C C T T C R I
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.64)
OVERALL
Model 95% CI
No interaction observed**
Table 3c.  Model Selection for HC with DeR
HC
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N OR ( ) p OR ( ) p
1 468 2.01 ( 0.68 , 5.92 ) 0.20 0.89 ( 0.19 , 4.19 ) 0.88
2 462 1.32 ( 0.39 , 4.54 ) 0.66 0.55 ( 0.11 , 2.77 ) 0.47
3 *F 416 1.34 ( 0.34 , 5.32 ) 0.68 0.37 ( 0.06 , 2.19 ) 0.28
*Final Model     F: Full Model    
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
CuR (Table 3d)   
Since there were no confounders identified for CuR, the full model used standard 
adjustment variables (Model 2) and resulted in no substantial change.  Therefore the 
standard-adjusted model was chosen as the final one (Model 1).  In both models, no 
significant association was observed.  The direction of association for the total sample 
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was positive (p=0.60), was positive in men [OR: 2.12 (0.53, 8.46); p=0.29], and inverse 
in women [OR: 0.61 (0.07, 4.97); p=0.64]. 
 
N OR ( ) p
1 468 1.22 ( 0.41 , 3.66 ) 0.72
2 * 462 1.35 ( 0.44 , 4.11 ) 0.60 X X X
I 462 R I
Table 3d.  Model Selection for HC with CuR
HC
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*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.99)
OVERALL
Model 95% CI
No interaction observed**
 
 
N OR ( ) p OR ( ) p
1 468 2.17 ( 0.57 , 8.29 ) 0.26 0.54 ( 0.07 , 4.30 ) 0.56
2 * 462 2.12 ( 0.53 , 8.46 ) 0.29 0.61 ( 0.07 , 4.97 ) 0.64
*Final Model     F: Full Model     
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
Recognition (Table 3e)   
Crude and adjusted models agreed in the total sample and in both gender strata for 
Recognition, showing an inverse association that strengthened and gained significance 
with adjustment.  However, no significance was observed in any model, therefore no 
model selection procedures were performed.  In the final model, the OR (95%CI) for the 
total sample was 0.38 (0.12, 1.15) (p=0.09)(Model 3).  In males, the point estimate for 
OR was 0.51 (0.13, 2.02), non-significant p=0.34, and in females it dropped substantially 
to 0.18 (0.02, 1.58), also non-significant at p=0.12. 
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N OR ( ) p
1 468 0.75 ( 0.30 , 1.90 ) 0.54
2 462 0.45 ( 0.16 , 1.30 ) 0.14 X X X
3 *F 419 0.38 ( 0.12 , 1.15 ) 0.09 C C T T C C
I 415 C C T T C C R I
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.98)
OVERALL
Model 95% CI
No interaction observed**
Table 3e.  Model Selection for HC with Recognition
HC
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N OR ( ) p OR ( ) p
1 468 0.98 ( 0.32 , 2.97 ) 0.97 0.32 ( 0.04 , 2.57 ) 0.29
2 462 0.58 ( 0.16 , 2.11 ) 0.41 0.25 ( 0.03 , 2.01 ) 0.19
3 *F 419 0.51 ( 0.13 , 2.02 ) 0.34 0.18 ( 0.02 , 1.58 ) 0.12
*Final Model     F: Full Model    
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
Stroop (Table 3f)   
The crude OR for low HC with poor outcome was initially positive at 1.64 (0.70, 
3.87) (p=0.26) in the total sample (Model 1), but after adjustment for standard variables 
dropped to unity (p=0.98) (Model 2).  After full adjustment (Model 3), the point estimate 
dropped somewhat further, leaving an OR of 0.81 (0.29, 2.25) p=0.68.  The male 
subsample exhibited positive associations in all models [final OR: 1.73 (0.43, 6.95); 
p=0.44], and the females exhibited inverse point estimates [final OR: 0.42 (0.08, 2.18); 
p=0.30].  No significant associations were observed. 
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N OR ( ) p
1 468 1.64 ( 0.70 , 3.87 ) 0.26
2 462 0.99 ( 0.37 , 2.64 ) 0.98 X X X
3 *F 419 0.81 ( 0.29 , 2.25 ) 0.68 C C T C C
I 415 C C T C C R I
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.30)
OVERALL
Model 95% CI
No interaction observed**
Table 3f.  Model Selection for HC with Stroop
HC
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N OR ( ) p OR ( ) p
1 468 2.88 ( 0.97 , 8.57 ) 0.06 0.71 ( 0.15 , 3.36 ) 0.67
2 462 2.06 ( 0.56 , 7.59 ) 0.28 0.45 ( 0.09 , 2.23 ) 0.33
3 *F 419 1.73 ( 0.43 , 6.95 ) 0.44 0.42 ( 0.08 , 2.18 ) 0.30
*Final Model     F: Full Model   
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
Trails (Table 3g)   
This analysis also showed a reversed direction from a positive crude estimate 
toward an increasingly inverse estimate throughout adjustment.  The total sample 
estimate dropped from a crude OR (95%CI) of 1.58 (0.67, 3.71) (p=0.30) to an OR of 
0.78 (0.28-2.19) (p=0.63) in the final model (Model 3).  The trend was the same in males 
and females, though the drop was more precipitous in males throughout adjustment [final 
Male OR: 0.40 (0.06, 2.52); p=0.33] whereas the female estimates approached unity 
[final Female OR: 1.12 (0.30, 4.21); p=0.87].  No associations were found to be 
significant, and no selection procedures were performed. 
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N OR ( ) p
1 468 1.58 ( 0.67 , 3.71 ) 0.30
2 462 0.91 ( 0.34 , 2.47 ) 0.85 X X X
3 *F 420 0.78 ( 0.28 , 2.19 ) 0.63 C C T C
I 416 C C T C R I
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.47)
OVERALL
Model 95% CI
No interaction observed**
Table 3g.  Model Selection for HC with Trails
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N OR ( ) p OR ( ) p
1 468 1.44 ( 0.44 , 4.74 ) 0.55 1.78 ( 0.52 , 6.15 ) 0.36
2 462 0.62 ( 0.12 , 3.32 ) 0.57 1.28 ( 0.35 , 4.60 ) 0.71
3 *F 420 0.40 ( 0.06 , 2.52 ) 0.33 1.12 ( 0.30 , 4.21 ) 0.87
*Final Model     F: Full Model    
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
Implicit (Table 3h) 
Only one potential confounder, IQ, was identified for this outcome. Though IQ 
has consistently remained a substantial confounder for most outcomes, it was found that 
its addition did not produce estimates that were substantially different from the crude 
estimates.  An additional model was run (not shown), including the standard adjustment 
variables and IQ, but the results were not substantially different from the standard 
adjusted model (Model 2).  The variable of impact in that model and Model 2 was 
determined to be education.  Since the model with education (Model 2) offered a 
noticeably more conservative estimate, and since it is in line with standard adjustment 
practices, Model 2 was adopted as final.  Nevertheless, no associations were significant.  
34 
The direction of the estimate in all models was positive for both the total and gender 
stratified samples. 
N OR ( ) p
1 468 1.51 ( 0.62 , 3.69 ) 0.37
2 * 462 1.22 ( 0.47 , 3.18 ) 0.69 X X X
3 F 464 1.43 ( 0.58 , 3.55 ) 0.44 C
I 458 X X X R I
*Final Model     F: Full Model     X: Standard Adjustment Variable     C: Confounder       T: 
Concomitant     I: Interaction     R: Required
**Term for interaction not statistically significant (p=0.99)
OVERALL
Model 95% CI
No interaction observed**
Table 3h.  Model Selection for HC with Implicit
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N OR ( ) p OR ( ) p
1 468 1.79 ( 0.54 , 5.93 ) 0.34 1.28 ( 0.33 , 4.93 ) 0.72
2 * 462 1.30 ( 0.33 , 5.09 ) 0.71 1.28 ( 0.33 , 5.01 ) 0.73
3 F 464 1.65 ( 0.48 , 5.66 ) 0.39 1.27 ( 0.33 , 4.91 ) 0.73
*Final Model     F: Full Model   
HC
(Stratified by Gender)
M F
Model 95% CI 95% CI
 
 
 
Interaction With APOE 
  No significant interactions were found by adding an interaction term for APOE 
and HC (and APOE itself in models that lacked this term).  P-values for the interaction 
term can be found in Model I in Tables 3a-h.  All p-values were above p=0.3 and did not 
meet the criteria for potential inference.  
Post hoc analysis of model fit with the inclusion of APOE revealed that model fit 
was significantly improved for ImR, CuR, Recognition, and Trails, though APOE did not 
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reach significance as a predictor for either of these models [ImR OR: 1.71 (0.93, 3.13), 
p=0.08; CuR OR: 0.92 (0.47, 1.82) p=0.81; Recogn. OR: 1.44 (0.83, 2.47), p=0.19; Trails 
OR: 0.92 (0.47, 1.82), p=0.39].  Neither term changed the measure of the association 
between HC and outcome.  The interaction term was found to improve the fit of the 
model beyond that observed for APOE singly for Recognition, however the parameter 
estimate and standard error were prohibitively large (β=15.56, SE=692.2) and indicated 
against interpretation. 
Given the lack of significance or model improvement with the addition of APOE 
or the interaction term, a two-by-two analysis was completed for HC with each outcome, 
stratified by APOE.  Examination of the tables showed that only two subjects possessed 
both low HC and at least one APOE ε4 allele, making impossible any meaningful 
interpretation of effect modification by APOE status. 
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Chapter 5 
Discussion 
 For the majority of cognitive outcomes assessed in this study, head circumference 
was not associated with poor cognitive outcomes. Of eight cognitive outcomes, one clear 
result, consistent with the brain reserve hypothesis and existing literature, emerged along 
with one suggestive but not statistically significant result that contradicted the a priori 
hypothesis.    
 The statistically significant finding for the association between low head 
circumference and poor 3MS outcome is consistent with the published literature.  While 
the 3MS has not previously been directly studied in relation to head size, results for the 
MMSE from which the 3MS was created have consistently shown a significant positive 
association with increasing head circumference in non-demented subjects39, 40 and with 
increasing intracranial volume in cognitively impaired subjects.29  The association 
between head size and outcome has also been observed for other measures of global 
cognition, such as a positive correlation between mean CASI scores, a measure very 
similar to the 3MS, and HC in a community sample of Japanese-Americans in the Kame 
Project,25 for several measures of general and specific intelligence scores with HC,40, 41 
intracranial area,42 and intracranial volume,26, 43 and for a modified Clinical Dementia 
Rating with intracranial area in a sample of female dementia patients.31  In all of the 
studies, these measures of association reached statistical significance.   
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 It is worth noting that the association between head circumference and 3MS in the 
current study remained statistically significant after adjustment for a measure of pre-
morbid IQ.  Measures of IQ provide an important control in the investigation of brain 
reserve, since it is itself hypothesized to be a form of reserve against cognitive decline 
independent of brain size.44  In our analysis, it was also one of the strongest confounders 
of association, not surprisingly given the well-known correlation between head size and 
measures of intelligence.26, 40-43, 68  Nevertheless, after adjustment for IQ, head 
circumference remained a strong independent predictor of 3MS scores in this sample. 
 The non-statistically significant trend of an inverse association of HC with 
recognition memory, which is contrary to our hypothesis, has no support from the 
existing literature.  Though AD patients are known to answer more positively in yes/no 
recognition trials, studies have shown that the discrimination scores on recognition 
subtests generally do not differ across groups with varying cognitive pathologies,69 and 
that the verbal recognition component of the HVLT, similar to recognition components 
on other verbal tests, does not improve the sensitivity and specificity of the HVLT scores 
in predicting later clinical decline into dementia.70, 71  Given its poor discrimination 
ability, one would not expect any significant deviation away from unity.   
In our sample, poor recognition outcome showed the expected associations with 
all confounders except height, in which there was a significant and slightly elevated 
association of poor outcome with increasing height that likely was a reflection of the 
association between height and HC.  It was positively correlated with intelligence, and 
remained so after adjustment in the full model, suggesting its similarity to other outcomes 
in terms of potential confounders.  Given this, it appears unlikely that some unknown 
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confounder could have generated the finding.  Nevertheless, the association indicated in 
this analysis merits further investigation in samples with perhaps a larger cognitively-
impaired subpopulation to more accurately study the effects of low head circumference 
on poor outcome. 
 The findings for HC with the remaining outcomes did not reach any inferential 
level of statistical significance in our sample.  Upon close inspection of the literature, 
particularly for immediate and delayed verbal recall, we find that this is not at odds with 
previously published investigations.  In several of the studies mentioned above with 
significant findings for measures of head size with global cognition and intelligence 
outcomes there has consistently been no association found between these measures and 
immediate or delayed recall tests similar in nature to that on the HVLT,40-43 despite the 
excellent early predictive value these tests have demonstrated for cognitive decline.70-74  
To date, there has been no research to support an association or lack thereof 
between HC and cued recall, the gain from cues that is particularly useful in predicting 
AD, other than generalized associations of this outcome with clinical disease.75, 76  
Logically, one could argue that accurate discriminators for AD or amnestic mild 
cognitive impairment would be poor candidates for associative analysis with a measure, 
such as HC, that is hypothesized to be protective of clinical manifestation for many types 
of progressive pathological insult, especially in a population that is likely demonstrating 
mixed pathologies through low cognitive outcomes.  Therefore, it is unsurprising that no 
association was observed for cued recall in this community sample with undefined 
pathologies. 
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Among the Stroop interference test, Trails difference score (see Methods), and the 
implicit memory test, only the Stroop test has been reported as having an association with 
head size.  Tisserand et al. found an inverse association with between time to complete 
the interference task and head circumference in least-squares regression (β from –1.18 to 
–1.48, depending on adjustment for age and sex alone, or with SES, height or 
education).40  In the current study, no significant association was observed between HC 
and number of words completed in a set time period (a direct association would be 
expected based on the reserve hypothesis and literature).  It is possible that the sample 
size, nearly twice as large in Tisserand et al. as compared to the current study, contributed 
to the difference in findings.   
By contrast, no findings have been reported for an association between HC and 
the Trails difference score or implicit memory, although Trails was among the cognitive 
tests performed by Wolf et al. in her comparison of HC and cognition among normal, 
MCI and demented subjects.27  As a measure of executive function,62, 77 poor outcome on 
the difference score is hypothesized to be associated with lower HC under the reserve 
hypothesis.  However, it is again possible that magnitude of the measure of association is 
too small to detect among a population of this size. 
It is worth discussing in more detail the difference in findings for an association 
between HC and the outcomes 3MS, Stroop and Trails, given that all three tests are 
measures of executive function and that their scores strongly correlate with each other 
(Pearson correlation coefficients in this sample range between 0.40 and 0.46, p<0.0001, 
data not shown).  The most likely explanation given the data in this sample is that the 
tests, measuring executive function by different means, demonstrate disparate true 
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associations with HC.  Crude analysis of the association between HC and these outcomes, 
given in Appendix A (Table A1), shows the initial difference in the effect sizes for HC on 
3MS and both Stroop and Trails, where for 3MS the OR>4.0 and for the latter two crude 
OR≈1.6.  In a retrospective power analysis under the assumption of an unmatched case 
control study with the given proportion of cases to controls and proportion of exposure to 
low HC among the controls, it was found that the power to detect an association at 
α=0.05 in this sample would fall dramatically for the three outcomes as the hypothetical 
association drops below an OR of about 3.  Given this and the initial differences in effect 
size, it seems entirely possible that the association between HC and both Stroop and 
Trails scores is low to moderate in this sample, and that there is likely insufficient power 
to detect a statistically significantly elevated risk of poor outcome. 
The eighth outcome in this analysis, implicit memory scores from a word-stem 
completion task, also failed to demonstrate a statistically significant association with 
dichotomous HC.  While there is no known literature on this association, existing 
literature on the association between Alzheimer’s disease case status and performance on 
word-stem completion tasks has generated mixed results.78-81  A meta-analysis attempting 
to overcome the limitations of smaller studies suggested a weak but statistically 
significant correlation between case status and word-stem completion scores.82  However, 
the authors cautioned that null findings should be interpreted carefully given the apparent 
need for large sample sizes and adequate power to detect the small association.  
Therefore, while the current analysis detected no statistically significant association 
between head size and cognitive outcome, the conclusion that there is no biological 
impact of head size on implicit memory scores can likely not be drawn from our data. 
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Apart from outcome-specific interpretations of these results, there are several 
points to consider in the analysis and interpretation of the overall findings.  First, the 
sample in the Charlotte County Healthy Aging Study was drawn from a population in a 
popular retirement location in Florida, subject to substantial migration.  It is likely that 
those migrating to the region might on average have higher income and better education, 
which would correlate with higher IQ scores, than those who do not.  This self-selection 
may explain the relatively high mean years of education and level of income among our 
sample.  These characteristics impart two possible implications for interpretation of the 
results.  First, higher education is known to be inversely associated with poor cognitive 
performance and dementia,83, 84 indicating that poor cognition may be less prevalent in 
this community sample than in other populations studied in North America or Europe.  
Since poor cognition was defined relatively (as a quantile) for analysis, this may have 
contributed to fewer findings among the eight outcomes.  Second, if the relative 
classification of poor cognition in this highly educated sample led to misclassification of 
truly poor cognition, it would indicate that the statistically significant finding that small 
head size predicted low 3MS scores might underestimate the true association with the 
same bottom quantile of scores among the general population. 
Another point of consideration is the use of multiple comparisons in this analysis.  
No corrections for multiple comparisons were used, which generally raises the possibility 
of finding a statistically significant association by chance.  This is of less concern in this 
analysis given that the eight endpoints were dependent (the correlation between them, 
data not shown, was observed to be between 0.3 and 0.7, excepting cued recall and 
implicit memory scores).  Nevertheless, since correction accounting for these correlations 
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may still place the required per-comparison allowable error below the observed p-value 
of 0.03 for a familywise error rate of α=0.05,85 the possibility should be considered that a 
Type I error may have occurred.  There are two reasons why it is unlikely that the single 
significant finding in this study is the result of Type I error.  First, the finding is 
substantially supported by similar results in previously published studies.  Second, the 
observations, consistent in male and female subjects, are supported by a biologically 
plausible hypothesis.  Therefore, it is concluded that in this sample the statistically 
significant association identified between head size and 3MS scores is likely valid. 
Finally, it was found that the interactive effects of APOE ε4 status could not be 
examined in this sample due to a very small number of subjects who had both low HC 
and possessed one or more APOE ε4 alleles (n=2).  Crude analysis indicated that APOE 
ε4-positive subjects performed less well on cognitive measures.  Post hoc analyses of 
model fit after failure to detect interaction also showed that inclusion of APOE 
statistically significantly improved the fit of the final models with immediate recall, 
recognition and trails.  The estimates of effect were generally too unstable to infer much 
from this information, although it was suggested that possession of an ε4 allele 
independently increased risk of poor outcome in the Trails test (p=0.08). 
In examining effect modification by APOE ε4 status, this analysis attempted to 
replicate the results found in the Kame Project, in which it was seen that the effect of 
head circumference on incident AD was restricted to those with one or more ε4 alleles.32, 
33  Had the data permitted, it was hypothesized that possession of an ε4 allele may have 
modified the association between HC and poor outcome such that the effect would have 
been stronger in ε4-positive subjects.  Given the significance of the findings from the 
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Kame Project, however, it is important that other large and well-designed studies with 
sufficient exposed individuals analyze these associations further so that risk of 
impairment can be accurately described with respect to head size and genetic risk of AD. 
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Appendix A: Additional Tables 
 OR ( ) p OR ( ) p OR ( ) p
4.38 ( 1.99 , 9.66 ) <0.001 3.09 ( 1.07 , 8.96 ) 0.04 6.58 ( 1.99 , 21.8 ) 0.002
1.62 ( 0.69 , 3.82 ) 0.27 1.37 ( 0.45 , 4.18 ) 0.58 1.90 ( 0.49 , 7.4 ) 0.35
1.54 ( 0.65 , 3.61 ) 0.33 2.01 ( 0.68 , 5.92 ) 0.21 0.89 ( 0.19 , 4.2 ) 0.88
1.22 ( 0.41 , 3.66 ) 0.72 2.17 ( 0.57 , 8.29 ) 0.26 0.54 ( 0.07 , 4.3 ) 0.56
0.75 ( 0.30 , 1.90 ) 0.54 0.98 ( 0.32 , 2.97 ) 0.97 0.32 ( 0.04 , 2.6 ) 0.29
1.64 ( 0.70 , 3.87 ) 0.26 2.88 ( 0.97 , 8.57 ) 0.06 0.71 ( 0.15 , 3.4 ) 0.67
1.58 ( 0.67 , 3.17 ) 0.30 1.44 ( 0.44 , 4.74 ) 0.55 1.78 ( 0.52 , 6.2 ) 0.36
1.51 ( 0.62 , 3.69 ) 0.37 1.79 ( 0.54 , 5.93 ) 0.34 1.28 ( 0.33 , 4.9 ) 0.72
Potential confounders assoc. with outcome and total-sample exposure at p<0.1
Discrim.
Stroop
Trails
Implicit
*Continous covariates. Crude OR is for probability of event (Low HC; Poor Outcome) with each increasing unit of the covariate: Age and 
Educ in yrs; Income in levels 1(<10k)-9(>150k); IQ in points; Height in inches.
**Categorical covariates. Crude OR is for probability of event with: Gender (female); BMI (obese); APOE (ε4+).
3MS
ImR
DeR
CuR
Table A. Unadjusted Logistic Regression of Head Circumference, Outcomes and Covariates
Table A1. Dichotomized Outcomes Modeled With Dichotomous Head Circumference (Crude)
Dichotomized 
Outcome
HC
OVERALL N=468 Male N=228 Female N=240
95% CI 95% CI 95% CI
 
58 
OR ( ) p OR ( ) p OR ( ) p
1.11 ( 1.07 , 1.16 ) <0.001 0.79 ( 0.73 , 0.87 ) <0.001 0.79 ( 0.51 , 1.22 ) 0.28
1.09 ( 1.05 , 1.13 ) <0.001 0.88 ( 0.82 , 0.95 ) 0.001 0.49 ( 0.31 , 0.77 ) 0.002
1.09 ( 1.05 , 1.13 ) <0.001 0.85 ( 0.78 , 0.92 ) <0.001 0.64 ( 0.41 , 1.00 ) 0.05
0.99 ( 0.95 , 1.04 ) 0.75 0.98 ( 0.89 , 1.07 ) 0.62 1.34 ( 0.77 , 2.33 ) 0.30
1.06 ( 1.02 , 1.09 ) 0.0012 0.91 ( 0.85 , 0.97 ) 0.0067 0.53 ( 0.35 , 0.80 ) 0.0026
1.11 ( 1.06 , 1.15 ) <0.001 0.82 ( 0.75 , 0.89 ) <0.001 1.09 ( 0.70 , 1.71 ) 0.69
1.11 ( 1.07 , 1.16 ) <0.001 0.80 ( 0.73 , 0.87 ) <0.001 1.12 ( 0.72 , 1.74 ) 0.62
1.02 ( 0.99 , 1.06 ) 0.24 0.95 ( 0.88 , 1.02 ) 0.16 1.24 ( 0.78 , 1.96 ) 0.37
OR ( ) p OR ( ) p OR ( ) p
0.69 ( 0.58 , 0.83 ) <0.001 0.84 ( 0.81 , 0.88 ) <0.001 0.96 ( 0.91 , 1.01 ) 0.13
0.76 ( 0.64 , 0.91 ) 0.002 0.91 ( 0.88 , 0.95 ) <0.001 1.06 ( 1.00 , 1.11 ) 0.05
0.72 ( 0.60 , 0.85 ) <0.001 0.89 ( 0.86 , 0.92 ) <0.001 1.01 ( 0.96 , 1.06 ) 0.80
1.01 ( 0.84 , 1.21 ) 0.94 0.97 ( 0.93 , 1.02 ) 0.25 0.99 ( 0.93 , 1.06 ) 0.78
0.89 ( 0.77 , 1.02 ) 0.10 0.92 ( 0.89 , 0.95 ) <0.001 1.05 ( 1.00 , 1.10 ) 0.05
0.72 ( 0.60 , 0.85 ) <0.001 0.92 ( 0.89 , 0.95 ) <0.001 0.94 ( 0.89 , 0.99 ) 0.03
0.65 ( 0.55 , 0.78 ) <0.001 0.90 ( 0.87 , 0.94 ) <0.001 0.98 ( 0.93 , 1.03 ) 0.36
0.88 ( 0.75 , 1.04 ) 0.13 0.97 ( 0.93 , 1.01 ) 0.10 0.97 ( 0.92 , 1.02 ) 0.22
*TABLE A2 CONTINED ON THE NEXT PAGE
**Continous covariates. Crude OR is for probability of event (Low HC; Poor Outcome) with each increasing unit of the covariate: Age and 
Educ in yrs; Income in levels 1(<10k)-9(>150k); IQ in points; Height in inches.
***Categorical covariates. Crude OR is for probability of event with: Gender (female); BMI (obese); APOE (ε4+).
Potential confounders assoc. with outcome and total-sample exposure at p<0.1
Discrim.
Stroop
Trails
Implicit
3MS
ImR
DeR
CuR
Dichotomized 
Outcome
Income** N=424 IQ** N=464 Height** N=465
95% CI 95% CI 95% CI
Discrim.
Stroop
Trails
Implicit
3MS
ImR
DeR
CuR
Table A2*. Dichotomized Outcomes Modeled With Covariates (Crude)
Dichotomized 
Outcome
Age** N=467 Education** N=463 Gender*** N=468
95% CI 95% CI 95% CI
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OR ( ) p OR ( ) p
0.81 ( 0.48 , 1.36 ) 0.42 1.15 ( 0.67 , 1.95 ) 0.62
0.67 ( 0.39 , 1.15 ) 0.15 1.30 ( 0.77 , 2.18 ) 0.32
1.02 ( 0.62 , 1.69 ) 0.92 1.62 ( 0.98 , 2.67 ) 0.06
0.97 ( 0.52 , 1.82 ) 0.94 0.91 ( 0.46 , 1.79 ) 0.79
1.11 ( 0.70 , 1.76 ) 0.65 1.39 ( 0.86 , 2.25 ) 0.17
0.79 ( 0.47 , 1.34 ) 0.39 0.94 ( 0.54 , 1.64 ) 0.83
0.93 ( 0.56 , 1.54 ) 0.78 1.65 ( 1.00 , 2.72 ) 0.52
1.21 ( 0.73 , 2.02 ) 0.46 1.13 ( 0.66 , 1.96 ) 0.65
*Continous covariates. Crude OR is for probability of event (Low HC; Poor Outcome) with each 
increasing unit of the covariate: Age and Educ in yrs; Income in levels 1(<10k)-9(>150k); IQ in 
points; Height in inches.
**Categorical covariates. Crude OR is for probability of event with: Gender (female); BMI (obese); 
APOE (ε4+).
Potential confounders assoc. with outcome and total-sample exposure at p<0.1
Table A2. Dichotomized Outcomes Modeled With Covariates (Crude) - Continued
Discrim.
Stroop
Trails
Implicit
3MS
ImR
DeR
CuR
Dichotomized 
Outcome
BMI** N=468 APOE** N=468
95% CI 95% CI
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OR ( ) p OR ( ) p OR ( ) p
1.06 ( 0.99 , 1.13 ) 0.09 1.01 ( 0.93 , 1.10 ) 0.85 1.13 ( 1.01 , 1.26 ) 0.03
0.86 ( 0.76 , 0.98 ) 0.02 0.83 ( 0.71 , 0.98 ) 0.02 0.90 ( 0.73 , 1.10 ) 0.30
0.75 ( 0.34 , 1.63 ) 0.47
0.92 ( 0.70 , 1.20 ) 0.52 0.79 ( 0.53 , 1.18 ) 0.25 1.03 ( 0.71 , 1.49 ) 0.88
0.92 ( 0.87 , 0.98 ) 0.004 0.91 ( 0.84 , 0.98 ) 0.01 0.94 ( 0.86 , 1.02 ) 0.14
0.91 ( 0.83 , 1.00 ) 0.05 0.83 ( 0.73 , 0.94 ) 0.0047 0.83 ( 0.67 , 1.03 ) 0.09
0.67 ( 0.24 , 1.72 ) 0.37 0.87 ( 0.27 , 2.82 ) 0.8111 0.30 ( 0.04 , 2.38 ) 0.25
0.28 ( 0.07 , 1.21 ) 0.09 0.32 ( 0.04 , 2.54 ) 0.28 0.25 ( 0.03 , 2.00 ) 0.19
Potential confounders assoc. with outcome and total-sample exposure at p<0.1
BMI**
APOE**
*Continous covariates. Crude OR is for probability of event (Low HC; Poor Outcome) with each increasing unit of the covariate: Age and 
Educ in yrs; Income in levels 1(<10k)-9(>150k); IQ in points; Height in inches.
**Categorical covariates. Crude OR is for probability of event with: Gender (female); BMI (obese); APOE (ε4+).
 --- 
Income*
IQ*
Height*
Age*
Education*
Gender**  --- 
Table A3 Dichotomized Head Circumference Modeled With Covariates (Crude)
Continous 
Covariates
HC
OVERALL M F
95% CI 95% CI 95% CI
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